You are currently browsing the archives for 29 October 2016.
Displaying 1 entry.

When researchers offer cash as an incentive to take part in the research.

The results represent a dilemma for those with ethical monitoring of human subjects of research applicable. ,, when researchers offer cash as an incentive to take part in the research, people could not participate in trials and thus much valuable research ‘is unlikely to be performed in a timely manner or at all is done. ‘Yet IRBs should not approve protocols – regardless of their social or scientific value – unless the possibility of coercion or undue influence has been minimized. Dilemma dilemma, the authors suggest that the political and educational efforts undertaken to clarify if the payment practices actually represents coercion and undue influence.

Now er’s Drug Discovery Foundation Funds development of clinical trials for Alzheimer’s diseaseThe Alzheimer’s Drug Discovery Foundation awarded the British firm Cambridge Cognition Ltd is a grant of $ 200,000 in its development of a clinical cognitive assessment product for Alzheimer’s support disease.